According to Assertio Therapeutics 's latest financial reports the company's current EPS (TTM) is $2.00. In 2022 the company made an earnings per share (EPS) of $2.29 an increase over its 2021 EPS that were of -$0.02000.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $2.00 | -12.66% |
2022 | $2.29 | -11550% |
2021 | -$0.02000 | -96.08% |
2020 | -$0.51 | -95.79% |
2019 | -$12.12 | -622.41% |
2018 | $2.32 | -135.58% |
2017 | -$6.52 | 13.19% |
2016 | -$5.76 | 13.39% |
2015 | -$5.08 | -156.44% |
2014 | $9.00 | 200% |
2013 | $3.00 | -238.89% |
2012 | -$2.16 | -140.6% |
2011 | $5.32 | 1562.5% |
2010 | $0.32 | -118.6% |
2009 | -$1.72 | 34.38% |
2008 | -$1.28 | -132% |
2007 | $4.00 | -203.09% |
2006 | -$3.88 | 51.56% |
2005 | -$2.56 | -16.88% |
2004 | -$3.08 | -38.4% |
2003 | -$5.00 | 32.98% |
2002 | -$3.76 | -48.35% |
2001 | -$7.28 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -$0.27 | -113.50% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -$1.00 | -150.00% | ๐บ๐ธ USA |